Skip to main content
Equibles
ABOS logo

ABOS · Acumen Pharmaceuticals, Inc. · Share Buybacks

Track ABOS — free

Use ABOS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.83 -0.33 (-10.32%)
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Accordingly, management has concluded that substantial doubt exists regarding our ability to continue as a going concern.”
View the 10-Q filed Aug 12, 2026
Market Cap
$229.97M
Shares
72.32M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2022-07-01 $50,000,000 — —
Key facts CIK 1576885 CUSIP 00509G209 13F (30d) 70 filings 70 filers Visit website Investor relations